Pharma News

Growing in severe poverty can adversely affect children's brain development, new research has found. The study was published in the journal JAMA Pediatrics.

Ezetimibe can reduce the cardiovascular problems in diabetes patients, says a new study. The drug achieved greater reductions in LDL cholesterol than statins alone, resulting in lower risks of cardiovascular events in patients with diabetes and the benefits observed in diabetics were greater than in those without diabetes.

A large clinical trial in the US has found that omega-3 supplements will not slow cognitive decline in older people, debunking earlier research that a diet high in omega-3 fatty acids can protect brain health. The paper was published in the Journal of the American Medical Association.

[adsense:336x280:8701650588]

Looking at bright screens before going to bed can affect the sleep patterns of young teenagers, reveals a new study. The study is published in the Journal of Clinical Endocrinology and Metabolism.

The Mankind Pharma has taken an initiative to spread awareness about the importance of having strong bones, among the masses. The company has been championing this cause with their specialized ‘D3 Must Campaign’ across the country by reaching out to various schools, institutes and corporates.

Children who develop close friendship early in life can be physically fit later in their adulthood, says a new research. The study was published in the journal Psychological Science.

Adaptive servo-ventilation (ASV) therapy increases mortality and should not be used to treat central sleep apnoea in heart failure patients with reduced ejection fraction, the SERVE-HF trial shows.

Researchers from University of Southern California have revealed that if your brain gets a chance to learn from its mistakes, it will turn failures in life into positive experiences. The paper is published in the journal Nature Communications.

Finasteride and Dutasteride are in the family of drugs known as 5alpha-reductase inhibitors (5A-RIs). They are often prescribed for the treatment of male pattern hair loss, known as alopecia, and benign prostate enlargement (BPH). A new study has revealed that these commonly prescribed medicines may lead to adverse sexual side effects such as loss of libido or erectile dysfunction. The study  appear online in Endocrine Reviews and Metabolic Disorders.